PSMD1 and infection: People with previous COVID-19 infection had higher S1 IgG antibody levels with both vaccines (mean index of 11.49 in Pfizer/BioNTech and 7 in CanSino) compared to participants without previous infection (mean of 7.89 in Pfizer/BioNTech and 3.9 in CanSino) [18].